(Q33545718)

27 July 2017

1 reference

title

The pruritus of cholestasis. (English)

1 reference

27 July 2017

Jones EA

1

1 reference

27 July 2017

Bergasa NV

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

29

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

1003-1006

1 reference

Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

The pruritus of cholestasis: from bile acids to opiate agonists

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Experimental study of itch stimuli in animals

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Effects of central administration of opioids on facial scratching in monkeys

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Opioid peptides and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Cholestasis in the male rat is associated with naloxone-reversible antinociception

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Central mu-opioid receptors are down-regulated in a rat model of cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Serotonin and nociception

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Ondansetron for the treatment of pruritus after spinal opioids.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Clinical applications of visual analogue scales: a critical review.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Improved device for measuring scratching activity in patients with pruritus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Rifampin relieves pruritus in children with cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Naltrexone and hepatotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Improvement of cholestatic pruritus by ondansetron

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Ondansetron for pruritus due to cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Rifampin-Induced Methadone Withdrawal

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Subhypnotic doses of propofol relieve pruritus associated with liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290450

7 January 2021

Identifiers

DOI

10.1002/HEP.510290450

1 reference

release_d4a5ytc2hzhh5lmnyx6f6mizqm

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4a5ytc2hzhh5lmnyx6f6mizqm

24 November 2022

mapped directly with Wikidata item

1 reference